{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T06:18:40Z","timestamp":1790230720277,"version":"4.1.0"},"reference-count":40,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2018,7,1]],"date-time":"2018-07-01T00:00:00Z","timestamp":1530403200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,7,1]],"date-time":"2018-07-01T00:00:00Z","timestamp":1530403200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"vor","delay-in-days":1461,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100009945","name":"Merck KGaA","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009945","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["kidney-international.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Kidney International"],"published-print":{"date-parts":[[2018,7]]},"DOI":"10.1016\/j.kint.2018.01.027","type":"journal-article","created":{"date-parts":[[2018,4,30]],"date-time":"2018-04-30T05:14:55Z","timestamp":1525065295000},"page":"102-113","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":73,"title":["Metformin prevents the development of severe chronic kidney disease and its associated mineral and bone disorder"],"prefix":"10.1016","volume":"94","author":[{"given":"Ellen","family":"Neven","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin","family":"Vervaet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kerstin","family":"Brand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulrike","family":"Gottwald-Hostalek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Britt","family":"Opdebeeck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annelies","family":"De Mar\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anja","family":"Verhulst","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Daniel","family":"Lalau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Said","family":"Kamel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc E.","family":"De Broe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick C.","family":"D\u2019Haese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.kint.2018.01.027_bib1","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1159\/000481951","article-title":"Renoprotective effect of metformin","volume":"138","author":"De Broe","year":"2018","journal-title":"Nephron"},{"key":"10.1016\/j.kint.2018.01.027_bib2","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1038\/ki.2010.11","article-title":"Metformin prevents experimental gentamicin-induced nephropathy by a mitochondria-dependent pathway","volume":"77","author":"Morales","year":"2010","journal-title":"Kidney Int"},{"key":"10.1016\/j.kint.2018.01.027_bib3","doi-asserted-by":"crossref","first-page":"F727","DOI":"10.1152\/ajprenal.00293.2013","article-title":"Induction of AMPK activity corrects early pathophysiological alterations in the subtotal nephrectomy model of chronic kidney disease","volume":"305","author":"Satriano","year":"2013","journal-title":"Am J Physiol Renal Physiol"},{"key":"10.1016\/j.kint.2018.01.027_bib4","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.mce.2015.06.006","article-title":"Metformin prevents renal interstitial fibrosis in mice with unilateral ureteral obstruction","volume":"412","author":"Cavaglieri","year":"2015","journal-title":"Mol Cell Endocrinol"},{"key":"10.1016\/j.kint.2018.01.027_bib5","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1001\/archinternmed.2009.20","article-title":"Long-term effects of metformin on metabolism and microvascular and macrovascular disease in patients with type 2 diabetes mellitus","volume":"169","author":"Kooy","year":"2009","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.kint.2018.01.027_bib6","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1111\/j.1464-5491.2005.01448.x","article-title":"Reduced cardiovascular morbidity and mortality associated with metformin use in subjects with type 2 diabetes","volume":"22","author":"Johnson","year":"2005","journal-title":"Diabet Med"},{"key":"10.1016\/j.kint.2018.01.027_bib7","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1016\/S0140-6736(98)07037-8","article-title":"Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group","volume":"352","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/j.kint.2018.01.027_bib8","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1177\/14746514070070050201","article-title":"Review: 50 years later: is metformin a vascular drug with antidiabetic properties?","author":"Wiernsperger","year":"2007","journal-title":"Br J Diabetes Vasc Dis"},{"key":"10.1016\/j.kint.2018.01.027_bib9","doi-asserted-by":"crossref","first-page":"e001202","DOI":"10.1161\/JAHA.114.001202","article-title":"Metformin beyond diabetes: pleiotropic benefits of metformin in attenuation of atherosclerosis","volume":"3","author":"Forouzandeh","year":"2014","journal-title":"J\u00a0Am Heart Assoc"},{"key":"10.1016\/j.kint.2018.01.027_bib10","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.2337\/db12-0533","article-title":"Dissociation of Bcl-2-Beclin1 complex by activated AMPK enhances cardiac autophagy and protects against cardiomyocyte apoptosis in diabetes","volume":"62","author":"He","year":"2013","journal-title":"Diabetes"},{"key":"10.1016\/j.kint.2018.01.027_bib11","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.4161\/auto.7.10.16740","article-title":"AMP-activated protein kinase modulates cardiac autophagy in diabetic cardiomyopathy","volume":"7","author":"Xie","year":"2011","journal-title":"Autophagy"},{"key":"10.1016\/j.kint.2018.01.027_bib12","doi-asserted-by":"crossref","first-page":"696","DOI":"10.2337\/db07-1098","article-title":"Acute metformin therapy confers cardioprotection against myocardial infarction via AMPK-eNOS-mediated signaling","volume":"57","author":"Calvert","year":"2008","journal-title":"Diabetes"},{"key":"10.1016\/j.kint.2018.01.027_bib13","doi-asserted-by":"crossref","first-page":"H2123","DOI":"10.1152\/ajpheart.00707.2010","article-title":"Enhancing AMPK activation during ischemia protects the diabetic heart against reperfusion injury","volume":"300","author":"Paiva","year":"2011","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.kint.2018.01.027_bib14","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1007\/s00395-007-0691-y","article-title":"Metformin protects the ischemic heart by the Akt-mediated inhibition of mitochondrial permeability transition pore opening","volume":"103","author":"Bhamra","year":"2008","journal-title":"Basic Res Cardiol"},{"key":"10.1016\/j.kint.2018.01.027_bib15","doi-asserted-by":"crossref","first-page":"2313","DOI":"10.1002\/jbmr.2585","article-title":"Disturbances in bone largely predict aortic calcification in an alternative rat model developed to study both vascular and bone pathology in chronic kidney disease","volume":"30","author":"Neven","year":"2015","journal-title":"J\u00a0Bone Miner Res"},{"key":"10.1016\/j.kint.2018.01.027_bib16","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1038\/sj.ki.5000414","article-title":"Definition, evaluation, and classification of renal osteodystrophy:a position statement from Kidney Disease:Improving Global Outcomes (KDIGO)","volume":"69","author":"Moe","year":"2006","journal-title":"Kidney Int"},{"key":"10.1016\/j.kint.2018.01.027_bib17","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1161\/ATVBAHA.110.204834","article-title":"Chondrocyte rather than osteoblast conversion of vascular cells underlies medial calcification in uremic rats","volume":"30","author":"Neven","year":"2010","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.kint.2018.01.027_bib18","first-page":"82","article-title":"Reversibility of adenine-induced renal failure in rats","volume":"3","author":"Okada","year":"1999","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.kint.2018.01.027_bib19","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/S2213-8587(15)00123-0","article-title":"Metformin use and mortality in patients with advanced chronic kidney disease:national, retrospective, observational, cohort study","volume":"3","author":"Hung","year":"2015","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/j.kint.2018.01.027_bib20","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1038\/ki.2014.19","article-title":"Metformin and other antidiabetic agents in renal failure patients","volume":"87","author":"Lalau","year":"2015","journal-title":"Kidney Int"},{"key":"10.1016\/j.kint.2018.01.027_bib21","doi-asserted-by":"crossref","first-page":"001076","DOI":"10.1136\/bmjopen-2012-001076","article-title":"Effectiveness and safety of metformin in 51 675 patients with type 2 diabetes and different levels of renal function: a cohort study from the Swedish National Diabetes Register","volume":"2","author":"Ekstrom","year":"2012","journal-title":"BMJ Open"},{"key":"10.1016\/j.kint.2018.01.027_bib22","doi-asserted-by":"crossref","first-page":"2291","DOI":"10.2337\/dc14-0464","article-title":"Incidence of lactic acidosis in patients with type 2 diabetes with and without renal impairment treated with metformin: a retrospective cohort study","volume":"37","author":"Richy","year":"2014","journal-title":"Diabetes Care"},{"key":"10.1016\/j.kint.2018.01.027_bib23","doi-asserted-by":"crossref","first-page":"2218","DOI":"10.2337\/dc13-3023","article-title":"Risk of lactic acidosis or elevated lactate concentrations in metformin users with renal impairment:a population-based cohort study","volume":"37","author":"Eppenga","year":"2014","journal-title":"Diabetes Care"},{"key":"10.1016\/j.kint.2018.01.027_bib24","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1097\/HJH.0b013e32835b15bb","article-title":"Cardiovascular disease in an adenine-induced model of chronic kidney disease:the temporal link between vascular calcification and haemodynamic consequences","volume":"31","author":"Shobeiri","year":"2013","journal-title":"J\u00a0Hypertens"},{"key":"10.1016\/j.kint.2018.01.027_bib25","doi-asserted-by":"crossref","first-page":"3680","DOI":"10.1210\/en.2013-1002","article-title":"Metformin inhibits vascular calcification in female rat aortic smooth muscle cells via the AMPK-eNOS-NO pathway","volume":"154","author":"Cao","year":"2013","journal-title":"Endocrinology"},{"key":"10.1016\/j.kint.2018.01.027_bib26","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1161\/CIRCRESAHA.116.308301","article-title":"Ablation of adenosine monophosphate-activated protein kinase alpha1 in vascular smooth muscle cells promotes diet-induced atherosclerotic calcification in\u00a0vivo","volume":"119","author":"Cai","year":"2016","journal-title":"Circ Res"},{"key":"10.1016\/j.kint.2018.01.027_bib27","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.vph.2016.01.002","article-title":"Metformin alleviates vascular calcification induced by vitamin D3 plus nicotine in rats via the AMPK pathway","volume":"81","author":"Zhang","year":"2016","journal-title":"Vasc Pharmacol"},{"key":"10.1016\/j.kint.2018.01.027_bib28","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/s12933-017-0509-7","article-title":"Association between metformin use and below-the-knee arterial calcification score in type 2 diabetic patients","volume":"16","author":"Mary","year":"2017","journal-title":"Cardiovasc Diabetol"},{"key":"10.1016\/j.kint.2018.01.027_bib29","doi-asserted-by":"crossref","first-page":"1856","DOI":"10.1681\/ASN.2010101110","article-title":"Warfarin-related nephropathy modeled by nephron reduction and excessive anticoagulation","volume":"22","author":"Ware","year":"2011","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.kint.2018.01.027_bib30","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1007\/s11255-017-1527-9","article-title":"Anticoagulant-related nephropathy:a case report and review of the literature of an increasingly recognized entity","volume":"49","author":"Kalaitzidis","year":"2017","journal-title":"Int Urol Nephrol"},{"key":"10.1016\/j.kint.2018.01.027_bib31","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.krcp.2014.11.001","article-title":"Anticoagulants and acute kidney injury:clinical and pathology considerations","volume":"33","author":"Brodsky","year":"2014","journal-title":"Kidney Res Clin Pract"},{"key":"10.1016\/j.kint.2018.01.027_bib32","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1038\/ki.2011.44","article-title":"Warfarin-related nephropathy occurs in patients with and without chronic kidney disease and is associated with an increased mortality rate","volume":"80","author":"Brodsky","year":"2011","journal-title":"Kidney Int"},{"key":"10.1016\/j.kint.2018.01.027_bib33","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1211\/jpp.60.12.0017","article-title":"Metformin regulates osteoblast and adipocyte differentiation of rat mesenchymal stem cells","volume":"60","author":"Gao","year":"2008","journal-title":"J\u00a0Pharm Pharmacol"},{"key":"10.1016\/j.kint.2018.01.027_bib34","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.bone.2010.04.596","article-title":"AMP-activated protein kinase (AMPK) activation regulates in\u00a0vitro bone formation and bone mass","volume":"47","author":"Shah","year":"2010","journal-title":"Bone"},{"key":"10.1016\/j.kint.2018.01.027_bib35","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1016\/j.bone.2010.12.003","article-title":"Metformin induces osteoblast differentiation via orphan nuclear receptor SHP-mediated transactivation of Runx2","volume":"48","author":"Jang","year":"2011","journal-title":"Bone"},{"key":"10.1016\/j.kint.2018.01.027_bib36","doi-asserted-by":"crossref","first-page":"2902","DOI":"10.1002\/jcb.23206","article-title":"Metformin stimulates osteoprotegerin and reduces RANKL expression in osteoblasts and ovariectomized rats","volume":"112","author":"Mai","year":"2011","journal-title":"J\u00a0Cell Biochem"},{"key":"10.1016\/j.kint.2018.01.027_bib37","doi-asserted-by":"crossref","first-page":"547","DOI":"10.2337\/dc17-2231","article-title":"Metformin treatment in patients with type 2 diabetes and chronic kidney disease stages 3A, 3B or 4","volume":"41","author":"Lalau","year":"2018","journal-title":"Diabetes Care"},{"key":"10.1016\/j.kint.2018.01.027_bib38","doi-asserted-by":"crossref","first-page":"2823","DOI":"10.1182\/blood-2006-07-035345","article-title":"Regression of warfarin-induced medial elastocalcinosis by high intake of vitamin K in rats","volume":"109","author":"Schurgers","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.kint.2018.01.027_bib39","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1038\/nmeth.2019","article-title":"Fiji: an open-source platform for biological-image analysis","volume":"9","author":"Schindelin","year":"2012","journal-title":"Nat Methods"},{"key":"10.1016\/j.kint.2018.01.027_bib40","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1002\/jbmr.1805","article-title":"Standardized nomenclature, symbols, and units for bone histomorphometry:a 2012 update of the report of the ASBMR Histomorphometry Nomenclature Committee","volume":"28","author":"Dempster","year":"2013","journal-title":"J\u00a0Bone Miner Res"}],"container-title":["Kidney International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0085253818301741?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0085253818301741?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T00:50:06Z","timestamp":1758761406000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0085253818301741"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7]]},"references-count":40,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,7]]}},"alternative-id":["S0085253818301741"],"URL":"https:\/\/doi.org\/10.1016\/j.kint.2018.01.027","relation":{},"ISSN":["0085-2538"],"issn-type":[{"value":"0085-2538","type":"print"}],"subject":[],"published":{"date-parts":[[2018,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Metformin prevents the development of severe chronic kidney disease and its associated mineral and bone disorder","name":"articletitle","label":"Article Title"},{"value":"Kidney International","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.kint.2018.01.027","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 International Society of Nephrology. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}